Immunocompetent PDMS-Free Organ-on-Chip Model of Cervical Cancer Integrating Patient-Specific Cervical Fibroblasts and Neutrophils

被引:3
|
作者
Kromidas, Elena [1 ]
Geier, Alicia [1 ]
Weghofer, Adrian [1 ]
Liu, Hui-Yu [1 ]
Weiss, Martin [2 ,3 ]
Loskill, Peter [1 ,2 ,4 ]
机构
[1] Eberhard Karls Univ Tubingen, Inst Biomed Engn, Fac Med, Dept Microphysiol Syst, D-72074 Tubingen, Germany
[2] Univ Tubingen, Dept Biomed & Mat Sci, NMI Nat & Med Sci Inst, D-72770 Reutlingen, Germany
[3] Eberhard Karls Univ Tubingen, Fac Med, Dept Womens Hlth, D-72076 Tubingen, Germany
[4] 3R Ctr Tubingen Vitro Models & Alternat Anim Testi, D-72074 Tubingen, Germany
关键词
cancer-on-chip; cervical cancer; cisplatin; microphysiological systems; neutrophils; organ-on-chip; TUMOR-ASSOCIATED NEUTROPHILS; HUMAN-PAPILLOMAVIRUS; EXTRACELLULAR TRAPS; CARCINOMA-CELLS; TUMORIGENESIS; ACTIVATION; CROSSTALK; INVASION; GROWTH; STROMA;
D O I
10.1002/adhm.202302714
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Despite preventive measures and available treatments, cervical cancer still ranks as the fourth most prevalent cancer among women worldwide and remains the leading cause of cancer death in women in many developing countries. To gain further insights into pathogenesis and to develop novel (immuno)therapies, more sophisticated human models recreating patient heterogeneities and including aspects of the tumor microenvironment are urgently required. A novel polydimethylsiloxane-free microfluidic platform, designed specifically for the generation and ccultivation of cervical cancerous tissue, is introduced. The microscale open-top tissue chambers of the cervical cancer-on-chip (CCoC) enable facile generation and long-term cultivation of SiHa spheroids in co-culture with donor-derived cervical fibroblasts. The resulting 3D tissue emulates physiological architecture and allows dissection of distinct effects of the stromal tissue on cancer viability and growth. Treatment with cisplatin at clinically-relevant routes of administration and dosing highlights the platform's applicability for drug testing. Moreover, the model is amenable for integration and recruitment of donor-derived neutrophils from the microvasculature-like channel into the tissue, all while retaining their ability to produce neutrophil extracellular traps. In the future, the immunocompetent CCoC featuring donor-specific primary cells and tumor spheroids has the potential to contribute to the development of new (immuno)therapeutic options. Cervical cancer still ranks as the fourth most prevalent cancer among women and remains the leading cause of cancer death in women in a wide range of developing countries. Hence, the cervical cancer-on-chip, a novel PDMS-free microfluidic platform designed specifically for the generation and cultivation of cervical cancerous tissue and perfusion of circulating immune cells, is developed.image
引用
收藏
页数:18
相关论文
共 21 条
  • [1] Membrane integration into PDMS-free microfluidic platforms for organ-on-chip and analytical chemistry applications
    Schneider, Stefan
    Gruner, Denise
    Richter, Andreas
    Loskill, Peter
    LAB ON A CHIP, 2021, 21 (10) : 1866 - 1885
  • [2] Peristaltic on-chip pump for tunable media circulation and whole blood perfusion in PDMS-free organ-on-chip and Organ-Disc systems
    Schneider, Stefan
    Bubeck, Marvin
    Rogal, Julia
    Weener, Huub J.
    Rojas, Cristhian
    Weiss, Martin
    Heymann, Michael
    van der Meer, Andries D.
    Loskill, Peter
    LAB ON A CHIP, 2021, 21 (20) : 3963 - 3978
  • [4] Exploring Osteoarthritis Dynamics: Patient-Specific Cartilage Samples in an Organ-on-a-Chip Model
    Pasztorek, Markus
    Fischer, Johanna
    Otahal, Alexander
    de Luna, Andrea
    Nehrer, Stefan
    Rosser, Julie
    CARTILAGE, 2024,
  • [5] Patient-Specific TCP Based on the gLQ Model-A Strong Outcome Predictor in Radiation Therapy for Cervical Cancer
    Huang, Z.
    Mayr, N. A.
    Lo, S. S.
    Harris, E. E.
    Yuh, K. A.
    Grecula, J. C.
    Yuh, W. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S43 - S44
  • [6] Normal Tissue Sparing with Patient-specific Margins in IMRT Boost Plans for Cervical Cancer
    Cabrera, A. R.
    Mader, B. C.
    Oldham, M.
    Taylor, B. N.
    Boyd, J. A.
    Jones, E. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S373 - S373
  • [7] Forecasting patient-specific dosimetric benefit from daily online adaptive radiotherapy for cervical cancer
    Ghimire, Rupesh
    Moore, Kevin L.
    Branco, Daniela
    Rash, Dominique L.
    Mayadev, Jyoti
    Ray, Xenia
    BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 2023, 9 (04)
  • [8] Studying the regression profiles of cervical tumours during radiotherapy treatment using a patient-specific multiscale model
    Kyroudis, Christos A.
    Dionysiou, Dimitra D.
    Kolokotroni, Eleni A.
    Stamatakos, Georgios S.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [9] Studying the regression profiles of cervical tumours during radiotherapy treatment using a patient-specific multiscale model
    Christos A. Kyroudis
    Dimitra D. Dionysiou
    Eleni A. Kolokotroni
    Georgios S. Stamatakos
    Scientific Reports, 9
  • [10] Feasibility Study of Patient-specific Quality Assurance System for High-dose-rate Brachytherapy in Patients with Cervical Cancer
    Lee, Boram
    Ahn, Sung Hwan
    Kim, Hyeyoung
    Han, Youngyih
    Huh, Seung Jae
    Kim, Jin Sung
    Kim, Dong Wook
    Sim, Jina
    Yoon, Myonggeun
    JOURNAL OF THE KOREAN PHYSICAL SOCIETY, 2016, 68 (08) : L1029 - L1036